Moderna, Inc. (FRA:0QF)
24.00
-0.44 (-1.80%)
Apr 28, 2025, 9:20 AM CET
Moderna Revenue
In the year 2024, Moderna had annual revenue of $3.24B USD, down -52.75%. Moderna had revenue of $966.00M in the quarter ending December 31, 2024, a decrease of -65.64%.
Revenue
$3.24B
Revenue Growth
-52.75%
P/S Ratio
2.96
Revenue / Employee
$557.93K
Employees
5,800
Market Cap
9.26B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Bayer Aktiengesellschaft | 46.61B |
Fresenius SE & Co. KGaA | 21.83B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Moderna News
- 2 days ago - Behind the Scenes of Moderna's Latest Options Trends - Benzinga
- 5 days ago - More Downside For Moderna Before The Breakthrough - Seeking Alpha
- 6 days ago - 33 Stocks That Could Rally 50% or More This Year - Kiplinger
- 7 days ago - Learn Investing: The Income Statement - Forexlive
- 10 days ago - Short bets against S&P 500 healthcare stock rise in March; MRNA stays top shorted - Seeking Alpha
- 17 days ago - Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - Wallstreet:Online
- 17 days ago - Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - Accesswire
- 18 days ago - Spotlight on Moderna: Analyzing the Surge in Options Activity - Benzinga